Behind The Knife: The Surgery Podcast cover image

Journal Review in Surgical Oncology: Gastric Cancer

Behind The Knife: The Surgery Podcast

00:00

Safety and MATTERHORN Limitations

Durvalumab did not increase severe toxicity or delay surgery, but immune adverse events, biomarker uncertainty, and limited generalizability remain concerns.

Play episode from 17:32
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app